ConductScience.org, home

Paper42953404PubMed

Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies.

Liu Q and 7 others. Front Cell Dev Biol, 2026.

Cite this record

ConductScience Library. Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies. Papers, record 42953404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42953404

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies.
Journal
Front Cell Dev Biol
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-30

Source PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu QQi
2Yu YYing
3Li WWenbo
4Chen XXinxu
5Shi ZZekai
6Li GGang
7Wei SShibo
8Luo ZZongjian

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References160

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122768835Metabolic regulation of epigenetics.Cell Metab2012https://conductscience.org/library/papers/22768835PubMed
230723290Epigenetic therapy in immune-oncology.Nat Rev Cancer2019https://conductscience.org/library/papers/30723290PubMed
341388204Author Correction: Cancer SLC43A2 alters T cell methionine metabolism and histone methylation.Nature2026https://conductscience.org/library/papers/41388204PubMed
439075148Epigenome editing technologies for discovery and medicine.Nat Biotechnol2024https://conductscience.org/library/papers/39075148PubMed
519230772Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.Lancet Oncol2009https://conductscience.org/library/papers/19230772PubMed
630725423Is the Hoffman Effect for Methionine Overuse Analogous to the Warburg Effect for Glucose Overuse in Cancer?Methods Mol Biol2019https://conductscience.org/library/papers/30725423PubMed
730613774Improving the metabolic fidelity of cancer models with a physiological cell culture medium.Sci Adv2019https://conductscience.org/library/papers/30613774PubMed
841596524Molecular and Immune Mechanisms Governing Cancer Metastasis, Including Dormancy, Microenvironmental Niches, and Tumor-Specific Programs.Int J Mol Sci2026https://conductscience.org/library/papers/41596524PubMed
938490978Dual inhibitors of DNMT and HDAC induce viral mimicry to induce antitumour immunity in breast cancer.Cell Death Discov2024https://conductscience.org/library/papers/38490978PubMed
1032854717Roles of METTL3 in cancer: mechanisms and therapeutic targeting.J Hematol Oncol2020https://conductscience.org/library/papers/32854717PubMed
1128581528DNA methylation variations are required for epithelial-to-mesenchymal transition induced by cancer-associated fibroblasts in prostate cancer cells.Oncogene2017https://conductscience.org/library/papers/28581528PubMed
1231564637An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer.Cancer Cell2019https://conductscience.org/library/papers/31564637PubMed
1329889360Cell cycle regulation of folate-mediated one-carbon metabolism.Wiley Interdiscip Rev Syst Biol Med2018https://conductscience.org/library/papers/29889360PubMed
1440028035Treating human cancer by targeting EZH2.Genes Dis2025https://conductscience.org/library/papers/40028035PubMed
1526411344Histone Methylation Dynamics and Gene Regulation Occur through the Sensing of One-Carbon Metabolism.Cell Metab2015https://conductscience.org/library/papers/26411344PubMed
1636979768Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.Biomedicines2023https://conductscience.org/library/papers/36979768PubMed
1733491748Serine, glycine and one‑carbon metabolism in cancer (Review).Int J Oncol2021https://conductscience.org/library/papers/33491748PubMed
1832276408Methionine Dependence of Cancer.Biomolecules2020https://conductscience.org/library/papers/32276408PubMed
1941388311EF24 targets METTL3 to reprogram m6A methylation and induce ferroptosis: an epitranscriptomic mechanism with therapeutical potential for glioma.Cell Commun Signal2025https://conductscience.org/library/papers/41388311PubMed
2041223330EZH2 Suppression Diversifies Prostate Cancer Lineage Variant Evolution and Lacks Efficacy in Inhibiting Disease Progression.Cancer Res2026https://conductscience.org/library/papers/41223330PubMed

See all 160 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42953404

GET https://conductscience.org/api/papers/v1/42953404/references?page=2